Cidofovir topical gel: GILD began a Phase I/II European trial in 60 immunocompetent patients infected with HPV.

Gilead Sciences Inc. (GILD), Foster City, Calif. Product: Cidofovir topical gel Indication: Human papilloma virus (HPV)-associated genital warts Status: GILD began a Phase I/II European trial in 60 im...